Abstract Medical device-associated infections are a serious medical threat, particularly for patients with impaired mobility and/or advanced age. Despite a variety of antimicrobial coatings for medical devices being explored to date, only a limited number have been introduced for clinical use. Research into new bactericidal agents with the ability to eradicate pathogens, limit biofilm formation, and exhibit satisfactory biocompatibility, is therefore necessary and urgent. In this study, a series of varied-morphology gold nanoparticles in shapes of rods, peanuts, stars and spherical-like, porous ones with potent antibacterial activity were synthesized and thoroughly tested against spectrum of Candida albicans, Pseudomonas aeruginosa, Staphyl...
The general focus of this thesis was the investigation and exploration of novel antibacterial and an...
The continued emergence of infectious diseases and the development of antimicrobial resistance repre...
Enteric bacterial human pathogens, i.e., Escherichia coli, Staphylococcus aureus, Bacillus subtilis ...
With soaring increase in the cases of multi-drug resistant (MDR) bacteria all over the world, we are...
As bacterial resistance is becoming increasingly serious, the development of antibacterial nanomater...
Despite much success in drug design and development, Pseudomonas aeruginosa is still considered as o...
We present the use of functionalized gold nanoparticles (AuNPs) to combat multi-drug-resistant patho...
In 2017 the World Health Organization (WHO) announced a list of the 12 multidrugresistant (MDR) fami...
In 2017 the World Health Organization (WHO) announced a list of the 12 multidrugresistant (MDR) fami...
The advent of new antibiotics has helped clinicians to control severe bacterial infections. Despite ...
Gold nanoparticles (AuNPs) of various shapes (including spheres, stars and flowers), with similar di...
We report a one-pot synthesis of spherical gold nanoparticles (52-22 nm) and their capping with cefa...
Gold nanoparticles (AuNPs) have gained increasing interest in recent times. This is greatly due to t...
The remarkable rise of antibiotic resistance among pathogenic bacteria poses a significant threat to...
The continued emergence of infectious diseases and the development of antimicrobial resistance repre...
The general focus of this thesis was the investigation and exploration of novel antibacterial and an...
The continued emergence of infectious diseases and the development of antimicrobial resistance repre...
Enteric bacterial human pathogens, i.e., Escherichia coli, Staphylococcus aureus, Bacillus subtilis ...
With soaring increase in the cases of multi-drug resistant (MDR) bacteria all over the world, we are...
As bacterial resistance is becoming increasingly serious, the development of antibacterial nanomater...
Despite much success in drug design and development, Pseudomonas aeruginosa is still considered as o...
We present the use of functionalized gold nanoparticles (AuNPs) to combat multi-drug-resistant patho...
In 2017 the World Health Organization (WHO) announced a list of the 12 multidrugresistant (MDR) fami...
In 2017 the World Health Organization (WHO) announced a list of the 12 multidrugresistant (MDR) fami...
The advent of new antibiotics has helped clinicians to control severe bacterial infections. Despite ...
Gold nanoparticles (AuNPs) of various shapes (including spheres, stars and flowers), with similar di...
We report a one-pot synthesis of spherical gold nanoparticles (52-22 nm) and their capping with cefa...
Gold nanoparticles (AuNPs) have gained increasing interest in recent times. This is greatly due to t...
The remarkable rise of antibiotic resistance among pathogenic bacteria poses a significant threat to...
The continued emergence of infectious diseases and the development of antimicrobial resistance repre...
The general focus of this thesis was the investigation and exploration of novel antibacterial and an...
The continued emergence of infectious diseases and the development of antimicrobial resistance repre...
Enteric bacterial human pathogens, i.e., Escherichia coli, Staphylococcus aureus, Bacillus subtilis ...